Artemis Investment Management LLP
Position in ELAN — Elanco Animal Health Inc
CIK 1535385
EDINBURGH, X0
Position in ELAN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$73,009,158
+$5,011,226 QoQ
Shares Held
2,966,646
+4.4% QoQ
Ownership
0.594%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#30
of 518 holders
Holding Since
Mar 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ELAN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Artemis Investment Management LLP holds $81,674,270 across 5 Drug Manufacturers - Specialty & Generic names. ELAN ranks #1 (89.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
This page
|
2,966,646 | $73,009,158 | |
| 2 | AMRX |
Amneal Pharmaceuticals, Inc.
|
186,125 | $3,221,823 | |
| 3 | COLL |
Collegium Pharmaceutical, Inc
|
68,573 | $2,482,342 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
28,176 | $2,332,409 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
15,319 | $628,538 |
All Filings in ELAN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,009,158 | 2,966,646 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $67,997,932 | 2,841,535 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $55,692,837 | 2,461,018 | Shares | Sole | 2026-02-02 | |
| 2020-03-31 | $3,323,235 | 148,425 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||